Focusing on developing safe and effective T-cell therapies with the potential to be widely accessible to cancer patients
Two proprietary platforms:
Artemis™
Utilizing the natural biology of T-cells to fight cancer
E-Alpha®
Leveraging antibody discovery platform to develop highly specific antibodies
A robust pipeline that encompasses T-cell therapies targeting a variety of tumor antigens
